Drug Safety

Tolcapone-Related Liver Dysfunction: Implications for Use in Parkinson's Disease Therapy
pp. 743-747(5)
Author: Borges N.

Drug-Induced Glaucomas: Mechanism and Management
pp. 749-767(19)
Authors: Tripathi R.C.; Tripathi B.J.; Haggerty C.

Benefits and Risks of Simvastatin in Patients with Familial Hypercholesterolaemia
pp. 769-786(18)
Authors: Mata P.; Alonso R.; Badimón J.J.

Safety and Pharmacology of Oseltamivir in Clinical Use
pp. 787-801(15)
Authors: Dutkowski R.; Thakrar B.; Froehlich E.; Suter P.; Oo C.; Ward P.

A Feasibility Study for Recording of Dispensing Errors and ‘Near Misses’ in Four UK Primary Care Pharmacies
pp. 803-813(11)
Authors: Chua S-S.; Wong I.C.K.; Edmondson H.; Allen C.; Chow J.; Peacham J.; Hill G.; Grantham J.

Hepatic Reactions During Treatment of Multiple Sclerosis with Interferon--1a: Incidence and Clinical Significance
pp. 815-827(13)
Authors: Francis G.S.; Grumser Y.; Alteri E.; Micaleff A.; O’Brien F.; Alsop J.; Moraga M.S.; Kaplowitz N.